Bluejay Diagnostics, Inc. Share Price & Technical Analysis
BJDX · $1.92 (-1.54%)
Healthcare / Medical Devices
$1.92
-1.54%
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoass…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
0% return in May, -11% avg return in past 3 year May month.
-26% return in 2026, -169% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 29% | -44% | -10% | 0% | 0% | – | – | – | – | – | – | – | -26% |
| 25 | -21% | 17% | -12% | -49% | -17% | 5% | -8% | -8% | 13% | 32% | -34% | -47% | -131% |
| 24 | -34% | -1% | 3% | -38% | 2% | -84% | -30% | -62% | -28% | -31% | -18% | 37% | -283% |
| 23 | 23% | 57% | -38% | -27% | -19% | 10% | 23% | -9% | -26% | -20% | -4% | -62% | -93% |
| 22 | -38% | -35% | 9% | 5% | -7% | -5% | 6% | -6% | -23% | 5% | -18% | -47% | -155% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.86M
P/E ratio
—
52W high
$16.68
52W low
$1.62
Volume
34,588
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Bluejay Diagnostics, Inc. share price today?
- Bluejay Diagnostics, Inc. (BJDX) last traded around $1.92 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BJDX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BJDX. Download the app for real-time alerts.
- How can I analyze Bluejay Diagnostics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.